These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28731238)

  • 41. Biosimilars: a systematic review of published and ongoing clinical trials of antipsoriatics in chronic inflammatory diseases.
    Nast A; Rosumeck S; Seidenschnur K
    J Dtsch Dermatol Ges; 2015 Apr; 13(4):294-300. PubMed ID: 25819235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of biologic agents in pediatric psoriasis.
    Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
    J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Data-driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine.
    van der Schoot LS; van den Reek JMPA
    Br J Dermatol; 2021 Oct; 185(4):698-699. PubMed ID: 34337747
    [No Abstract]   [Full Text] [Related]  

  • 44. Costs of Common Psoriasis Medications, 2010-2014.
    James SM; Hill DE; Feldman SR
    J Drugs Dermatol; 2016 Mar; 15(3):305-8. PubMed ID: 26954315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hidden treasures: exploring selective publication of trials and trial outcomes in biological treatment for plaque psoriasis.
    Mashayekhi S; Nast A; Gaskins M; Ahmed S; Turner EH; Flohr C
    Br J Dermatol; 2019 Sep; 181(3):601-602. PubMed ID: 30756373
    [No Abstract]   [Full Text] [Related]  

  • 46. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D; Strober BE
    Semin Cutan Med Surg; 2010 Mar; 29(1):28-34. PubMed ID: 20430305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C; Marshman G; Grillo M; Stanford T
    Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
    Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psoriasis Trends and Practice Gaps.
    Gottlieb AB; Greb JE; Goldminz AM
    Dermatol Clin; 2016 Jul; 34(3):235-42. PubMed ID: 27363878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of biologics in the treatment of moderate-to-severe plaque psoriasis.
    Puig L
    G Ital Dermatol Venereol; 2017 Feb; 152(1):28-35. PubMed ID: 27627100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrodermic psoriasis: current and future role of biologicals.
    Stinco G; Errichetti E
    BioDrugs; 2015 Apr; 29(2):91-101. PubMed ID: 25752640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depression? It's the Disease NOT the Drug.
    Kircik LH
    J Drugs Dermatol; 2018 Aug; 17(8):s28. PubMed ID: 30124736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The future of biological therapies.
    Warren RB; Griffiths CE
    Semin Cutan Med Surg; 2010 Mar; 29(1):63-6. PubMed ID: 20430310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New topical psoriasis treatment.
    Holdcroft C
    Nurse Pract; 1995 Mar; 20(3):15-6. PubMed ID: 7761036
    [No Abstract]   [Full Text] [Related]  

  • 55. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of new biological therapy in psoriasis treatment].
    Cortijo Cascajares S; García Rodríguez MP; Campo Angora M; Serrano Garrote O; Herreros de Tejada A
    Farm Hosp; 2004; 28(3):192-200. PubMed ID: 15222873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [On therapeutic-clinical research in psoriasis vulgaris].
    Heite HJ
    Arch Klin Exp Dermatol; 1966; 227(1):249-55. PubMed ID: 4862053
    [No Abstract]   [Full Text] [Related]  

  • 58. A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis.
    Bardazzi F; Antonucci VA; Tengattini V; Odorici G; Balestri R; Patrizi A
    J Dtsch Dermatol Ges; 2013 Nov; 11(11):1065-70. PubMed ID: 24119121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcipotriene for psoriasis.
    Med Lett Drugs Ther; 1994 Aug; 36(928):70-1. PubMed ID: 8035754
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of biologics in psoriasis patients under hemodialysis.
    Larquey M; Girard C; Sbidian E; Richard MA; Aubin F; Schmutz JL
    Eur J Dermatol; 2017 Oct; 27(5):531-533. PubMed ID: 28944757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.